© 2003 by European Society of Cardiology
Copyright © 2003, European Society of Cardiology
Cardiac specific differentiation of mouse embryonic stem cells
Center of Physiology and Pathophysiology, Department of Neurophysiology, University of Cologne, Robert-Koch-Strasse 39, Cologne D-50931, Germany
a.sachinidis{at}uni-koeln.de
* Corresponding author. Tel.: +49-221-478-7373; fax: +49-221-478-6965.
Embryonic stem (ES) cells may represent an alternative source of functionally intact cardiomyocytes for the causal treatment of cardiovascular diseases. However, this requires cardiac-specific differentiation of stem cells and the selection of pure lineages consisting of early embryonic cardiomyocytes. Therefore, an understanding of the basic mechanisms of heart development is essential for selective differentiation of embryonic stem cells into cardiac cells. The development of cardiac cells from embryonic stem cells is regulated by several soluble factors and signalling molecules together with cardiac specific transcription factors such as the zinc-finger GATA proteins and Nkx-2.5. GATA-4 and Nkx-2.5 seem to be essential for heart development. The use of enhanced green fluorescent protein (EGFP) under the control of cardiac-specific promoters in combination with the ES cell system has allowed for the functional characterisation of cardiac precursor cells. Embryonic stem cell-derived cardiomyocytes developmentally express similar cardiac-specific proteins, ion channels and signalling molecules to that of adult cardiomyocytes. Furthermore, identification of growth factors and signalling molecules under cell culture conditions is crucial for the selective cardiac differentiation of embryonic stem cells. Therefore, serum-free culture conditions have to be established in order to examine the influence of different growth factors and signalling molecules on cardiac development and/or formation from ES cells. Although significant progress has been made in generating cardiac cell lineage by the combination of genetically manipulative methods with selective culture conditions for cell transplantation therapy, one of the remaining future challenges for transplantation in humans is the immunological rejection of the engrafted cardiomyocytes.
KEYWORDS Embryonic stem cells; Cardiomyocytes; Signalling molecules; Growth factors
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. D. Boudoulas and A. K. Hatzopoulos Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease Dis. Model. Mech., July 1, 2009; 2(7-8): 344 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Takei, H. Ichikawa, K. Johkura, A. Mogi, H. No, S. Yoshie, D. Tomotsune, and K. Sasaki Bone morphogenetic protein-4 promotes induction of cardiomyocytes from human embryonic stem cells in serum-based embryoid body development Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1793 - H1803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Buesen, E. Genschow, B. Slawik, A. Visan, H. Spielmann, A. Luch, and A. Seiler Embryonic Stem Cell Test Remastered: Comparison between the Validated EST and the New Molecular FACS-EST for Assessing Developmental Toxicity In Vitro Toxicol. Sci., April 1, 2009; 108(2): 389 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Buggisch, B. Ateghang, C. Ruhe, C. Strobel, S. Lange, M. Wartenberg, and H. Sauer Stimulation of ES-cell-derived cardiomyogenesis and neonatal cardiac cell proliferation by reactive oxygen species and NADPH oxidase J. Cell Sci., March 1, 2007; 120(5): 885 - 894. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Behfar, C. Perez-Terzic, R. S. Faustino, D. K. Arrell, D. M. Hodgson, S. Yamada, M. Puceat, N. Niederlander, A. E Alekseev, L. V. Zingman, et al. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair J. Exp. Med., February 19, 2007; 204(2): 405 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Clement, M. Stouffs, E. Bettiol, S. Kampf, K.-H. Krause, C. Chaponnier, and M. Jaconi Expression and function of {alpha}-smooth muscle actin during embryonic-stem-cell-derived cardiomyocyte differentiation J. Cell Sci., January 15, 2007; 120(2): 229 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schmelter, B. Ateghang, S. Helmig, M. Wartenberg, and H. Sauer Embryonic stem cells utilize reactive oxygen species as transducers of mechanical strain-induced cardiovascular differentiation FASEB J, June 1, 2006; 20(8): 1182 - 1184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fukuda and S. Yuasa Stem Cells as a Source of Regenerative Cardiomyocytes Circ. Res., April 28, 2006; 98(8): 1002 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hakuno, T. Takahashi, J. Lammerding, and R. T. Lee Focal Adhesion Kinase Signaling Regulates Cardiogenesis of Embryonic Stem Cells J. Biol. Chem., November 25, 2005; 280(47): 39534 - 39544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-J. Swijnenburg, M. Tanaka, H. Vogel, J. Baker, T. Kofidis, F. Gunawan, D. R. Lebl, A. D. Caffarelli, J. L. de Bruin, E. V. Fedoseyeva, et al. Embryonic Stem Cell Immunogenicity Increases Upon Differentiation After Transplantation Into Ischemic Myocardium Circulation, August 30, 2005; 112(9_suppl): I-166 - I-172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kawamura, K. Ono, T. Morimoto, H. Wada, M. Hirai, K. Hidaka, T. Morisaki, T. Heike, T. Nakahata, T. Kita, et al. Acetylation of GATA-4 Is Involved in the Differentiation of Embryonic Stem Cells into Cardiac Myocytes J. Biol. Chem., May 20, 2005; 280(20): 19682 - 19688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Liao Yin and Yang of Myocardial Transforming Growth Factor-{beta}1: Timing Is Everything Circulation, May 17, 2005; 111(19): 2416 - 2417. [Full Text] [PDF]
|
|
|
|
|
|
M. Iida, T. Heike, M. Yoshimoto, S. Baba, H. Doi, and T. Nakahata Identification of cardiac stem cells with FLK1, CD31, and VE-cadherin expression during embryonic stem cell differentiation FASEB J, March 1, 2005; 19(3): 371 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hattan, H. Kawaguchi, K. Ando, E. Kuwabara, J. Fujita, M. Murata, M. Suematsu, H. Mori, and K. Fukuda Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice Cardiovasc Res, February 1, 2005; 65(2): 334 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. White and W. C. Claycomb Embryonic stem cells form an organized, functional cardiac conduction system in vitro Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H670 - H679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Satin, I. Kehat, O. Caspi, I. Huber, G. Arbel, I. Itzhaki, J. Magyar, E. A. Schroder, I. Perlman, and L. Gepstein Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes J. Physiol., September 1, 2004; 559(2): 479 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Hodgson, A. Behfar, L. V. Zingman, G. C. Kane, C. Perez-Terzic, A. E. Alekseev, M. Puceat, and A. Terzic Stable benefit of embryonic stem cell therapy in myocardial infarction Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H471 - H479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. Heng, H. K. Haider, E. K.-W. Sim, T. Cao, and S. C. Ng Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro Cardiovasc Res, April 1, 2004; 62(1): 34 - 42. [Abstract] [Full Text] [PDF]
|
|